All anti-HBc-positive, HBsAg-negative dialysis patients on the transplant waiting list should be regarded as at risk of hepatitis B reactivation post-renal transplantation--report of three cases from a single centre.
Roberts
Rhys Clwyd
RC
Department of Immunology, Imperial College London, Renal Section, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.
Lane
Catherine
C
Hatfield
Peter
P
Clutterbuck
Elaine
E
Atkins
Mark
M
Brown
Ashley
A
Dorling
Anthony
A
D006510:Hepatitis B Antibodies / Q000096:biosynthesis* / Q000097:blood; D006512:Hepatitis B Core Antigens / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006515:Hepatitis B virus / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000276:immunology* / Q000821:virology; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012307:Risk Factors; D009927:Tissue and Organ Procurement; D014775:Virus Activation; D014850:Waiting Lists
D006510:Hepatitis B Antibodies; D006512:Hepatitis B Core Antigens; D006514:Hepatitis B Surface Antigens